INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Total Non-Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹10 Cr | ₹11 Cr | ₹8.97 Cr | ₹8.10 Cr | ₹5.27 Cr |
What is the latest Total Non-Current Assets ratio of INDO US BIOTECH ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹10 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹8.97 Cr |
| Mar2022 | ₹8.10 Cr |
| Mar2021 | ₹5.27 Cr |
How is Total Non-Current Assets of INDO US BIOTECH Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹10 Cr | -2.66 | |
| Mar2024 | ₹11 Cr | 19.34 | |
| Mar2023 | ₹8.97 Cr | 10.73 | |
| Mar2022 | ₹8.10 Cr | 53.68 | |
| Mar2021 | ₹5.27 Cr | - | |
Compare Total Non-Current Assets of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹178.6 Cr | -9% | -17.1% | -41.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,481.9 Cr | 1.7% | -8% | -39.1% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,922.5 Cr | -2.6% | -18.7% | -15.3% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,051.4 Cr | -0.6% | 4.5% | 6.5% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,010.3 Cr | 3.5% | NA | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹526.6 Cr | 3.1% | 18.8% | 35.2% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -9% |
-17.1% |
-41.7% |
| SENSEX | -0.7% |
-2.9% |
-8.9% |
You may also like the below Video Courses